179 related articles for article (PubMed ID: 17577135)
1. Stem cell mechanisms and paracrine effects: potential in cardiac surgery.
Crisostomo PR; Wang M; Markel TA; Lahm T; Abarbanell AM; Herrmann JL; Meldrum DR
Shock; 2007 Oct; 28(4):375-83. PubMed ID: 17577135
[TBL] [Abstract][Full Text] [Related]
2. Stem cells: the building blocks to repair the injured heart.
Van Oorschot AA; Smits AM; Goumans MJ
Panminerva Med; 2010 Jun; 52(2):97-110. PubMed ID: 20517194
[TBL] [Abstract][Full Text] [Related]
3. Endogenous cardiac stem cells.
Barile L; Messina E; Giacomello A; Marbán E
Prog Cardiovasc Dis; 2007; 50(1):31-48. PubMed ID: 17631436
[TBL] [Abstract][Full Text] [Related]
4. Lost and found: cardiac stem cell therapy revisited.
Chien KR
J Clin Invest; 2006 Jul; 116(7):1838-40. PubMed ID: 16823485
[TBL] [Abstract][Full Text] [Related]
5. Stem cell therapy for ischemic heart disease: where are we?
LaPar DJ; Kron IL; Yang Z
Curr Opin Organ Transplant; 2009 Feb; 14(1):79-84. PubMed ID: 19337151
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue.
Zhu XY; Zhang XZ; Xu L; Zhong XY; Ding Q; Chen YX
Biochem Biophys Res Commun; 2009 Feb; 379(4):1084-90. PubMed ID: 19146824
[TBL] [Abstract][Full Text] [Related]
7. Suppression of kindled seizures by paracrine adenosine release from stem cell-derived brain implants.
Güttinger M; Fedele D; Koch P; Padrun V; Pralong WF; Brüstle O; Boison D
Epilepsia; 2005 Aug; 46(8):1162-9. PubMed ID: 16060924
[TBL] [Abstract][Full Text] [Related]
8. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium.
Tse HF; Siu CW; Zhu SG; Songyan L; Zhang QY; Lai WH; Kwong YL; Nicholls J; Lau CP
Eur J Heart Fail; 2007 Aug; 9(8):747-53. PubMed ID: 17481945
[TBL] [Abstract][Full Text] [Related]
9. Trans-coronary transplantation may be an optimal route in cellular cardiomyoplasty with stem cells.
Li ZZ; Bai SG; Huang J; Qian HY
Med Hypotheses; 2007; 69(6):1212-8. PubMed ID: 17555882
[TBL] [Abstract][Full Text] [Related]
10. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells.
Rossini A; Zacheo A; Mocini D; Totta P; Facchiano A; Castoldi R; Sordini P; Pompilio G; Abeni D; Capogrossi MC; Germani A
J Mol Cell Cardiol; 2008 Apr; 44(4):683-93. PubMed ID: 18328501
[TBL] [Abstract][Full Text] [Related]
11. Cardiac stem cell research: an elephant in the room?
Di Felice V; De Luca A; Colorito ML; Montalbano A; Ardizzone NM; Macaluso F; Gammazza AM; Cappello F; Zummo G
Anat Rec (Hoboken); 2009 Mar; 292(3):449-54. PubMed ID: 19248173
[TBL] [Abstract][Full Text] [Related]
12. Bone-marrow-derived cells and heart repair.
Clavel C; Verfaillie CM
Curr Opin Organ Transplant; 2008 Feb; 13(1):36-43. PubMed ID: 18660705
[TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cell-based neovascularization: implications for therapy.
Krenning G; van Luyn MJ; Harmsen MC
Trends Mol Med; 2009 Apr; 15(4):180-9. PubMed ID: 19303359
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms.
Weil BR; Markel TA; Herrmann JL; Abarbanell AM; Meldrum DR
Surgery; 2009 Aug; 146(2):190-7. PubMed ID: 19628073
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?
Mishra PK
J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):122-8. PubMed ID: 18192802
[TBL] [Abstract][Full Text] [Related]
16. Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies.
Cheng AS; Yau TM
Semin Thorac Cardiovasc Surg; 2008; 20(2):94-101. PubMed ID: 18707640
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
[TBL] [Abstract][Full Text] [Related]
18. Large animal models for cardiac stem cell therapies.
Gandolfi F; Vanelli A; Pennarossa G; Rahaman M; Acocella F; Brevini TA
Theriogenology; 2011 May; 75(8):1416-25. PubMed ID: 21463721
[TBL] [Abstract][Full Text] [Related]
19. Cell therapy in myocardial infarction.
Collins SD; Baffour R; Waksman R
Cardiovasc Revasc Med; 2007; 8(1):43-51. PubMed ID: 17293268
[TBL] [Abstract][Full Text] [Related]
20. Stem cell therapy for cardiac repair: benefits and barriers.
Joggerst SJ; Hatzopoulos AK
Expert Rev Mol Med; 2009 Jul; 11():e20. PubMed ID: 19586557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
